Summary
Gland Pharmas Pashamylaram facility has received GMP compliance certification from the Danish Medicines Agency for aseptically prepared powder products. Shares of Gland Pharma Ltd ended at 1,857.90,
Source: CNBCTV18
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
